Issue of Convertible Security

RNS Number : 8474E
Alba Mineral Resources PLC
03 March 2020
 

Alba Mineral Resources plc

(" Alba " or the " Company ")

 

Issue of Convertible Security

Alba Mineral Resources plc (AIM: ALBA), the diversified mineral exploration and development company makes this announcement further to its announcement of 24 February 2020 regarding the convertible securities issuance deed (the "Agreement") which the Company has entered into with a U.S.-based institutional investment fund managed by Bergen Asset Management, LLC (the "Investor") to provide up to £1,054,500 of funding in the form of the issuance by the Company of unsecured zero coupon convertible securities (the "Convertible Securities"). 

In accordance with the Agreement, the Company has issued a Convertible Security with the nominal value of £223,000 (at the purchase price of £192,000) on, and subject to, the terms and conditions set out in the Agreement, the details of which were disclosed to the market in the Company's announcement of 24 February 2020.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information, please contact:

 

Alba Mineral Resources plc

George Frangeskides, Executive Chairman

+44 20 3907 4297

 



Cairn Financial Advisers LLP ( Nomad

James Caithie / Liam Murray

+44 20 7213 0880

 



First Equity Limited (Broker)

Jason Robertson

+44 20 7374 2212

 



Alba's Project and Investment Portfolio

 

Project (commodity)

Location

Ownership

Mining Projects

Amitsoq (graphite)

Greenland

90%

Clogau (gold)

Wales

90%

Inglefield (copper, cobalt, gold)

Greenland

100%

Limerick (zinc-lead)

Ireland

100%

Melville Bay (iron ore)

Greenland

51%

TBS (ilmenite)

Greenland

100%

Oil & Gas Investments

Brockham (oil)

England

5%

Horse Hill (oil)

England

11.765%

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBXLFBBXLFBBZ
UK 100